On 1 May, the US National Institutes of Health (NIH), which is the largest public funder of biomedical research globally, published a new policy prohibiting all foreign sub-awards. As a result, billions of rands in research grants for South African clinical studies are unlikely to be renewed over the next year, GroundUp and Spotlight report.
